Wolters Kluwer Health today announced it has entered into an expanded distribution agreement with the New England Journal of Medicine (NEJM), the “gold standard” for quality biomedical research and for the best practices in clinical medicine. Under the terms of the agreement, Ovid, part of Wolters Kluwer Health, will be the only medical research aggregator to distribute current, non-embargoed NEJM content to institutions and their clinicians, researchers and students who need fast access to the latest medical and clinical literature. The OvidSP medical research platform is used by more than 12,500 institutions worldwide.
Ovid customers will have site-wide access to current issues of the New England Journal of Medicine through 1990 in PDF format, plus links to Online First articles. Ovid had previously offered NEJM content through 1993, as HTML only.
“After an extensive review of the current and future positioning of NEJM, we are pleased to be partnering with Wolters Kluwer Health,” said Thomas Easley, Publisher of the New England Journal of Medicine. “The OvidSP research solution offers NEJM added global reach, allowing us to bring important medical research and clinical content to even more healthcare professionals and researchers than ever before.”
“We are delighted to expand our relationship with the New England Journal of Medicine to offer our customers the most authoritative and influential medical periodical for physicians, researchers, students and healthcare professionals in the world,” said Karen Abramson, President & CEO of Wolters Kluwer Health Medical Research. “We’re particularly excited to make this invaluable content accessible to even more users in the global healthcare community, reaching important emerging markets to fuel research and improve clinical outcomes,” said Karen Abramson, President & CEO of Wolters Kluwer Health Medical Research.